Table 3 Statistical results of the correlation between relevant clinical trials in the pterygium group.

From: Evaluation of lymphotoxin-alpha in pterygium and diagnostic value in active and inactive pterygium states

 

LT-a

Pterygium level

Active pterygium

R

P

R

P

R

P

Sex

− 0.063

0.410

0.106

0.164

− 0.071

0.351

Age

− 0.166

0.029

0.292

< 0.001

0.207

0.006

Disease time (years)

0.181

0.024

0.208

< 0.001

0.157

0.011

Pterygium size (mm)

− 0.215

0.004

0.718

< 0.001

0.375

< 0.001

Congestion score

− 0.062

0.412

0.424

< 0.001

0.349

< 0.001

LT-a (ng/ml)

1

–

− 0.215

0.004

− 0.421

< 0.001

TMH (mm)

− 0.129

0.090

− 0.029

0.700

0.024

0.751

NIBUT (s)

− 0.028

0.709

− 0.410

< 0.001

− 0.110

0.148

CFS

− 0.060

0.433

0.420

< 0.001

0.274

< 0.001

MGS (up)

0.041

0.586

0.161

0.034

− 0.018

0.808

MGS (down)

0.063

0.409

0.145

0.056

0.025

0.735

LLT

− 0.234

0.001

0.270

< 0.001

0.082

0.280

  1. LLT lipid layer thickness, TMH tear meniscus height, NIBUT non-invasive break-up time, CFS corneal fluorescein staining, MGS meibomian gland score.
Back to article page